Bulevirtide
Bulevirtide is indicated for the treatment of chronic hepatitis delta virus (HDV) infection in plasma (or serum) HDV-RNA positive adult patients with compensated liver disease. Reference standards of Bulevirtide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Bulevirtide
[catalogue_number] => PA 02 2450000
[category_ids] => ,70,78,82,97,114,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => 2012558-47-1
[pslug] => 2012558-47-1-bulevirtide-api-pa022450000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
